Question 1

What stocks has Balthaser Kevin been buying?

Accepted Answer

InsiderAct tracks all open-market stock purchases disclosed by Balthaser Kevin via SEC Form 4 filings. These are publicly disclosed transactions that corporate insiders must file with the SEC within 2 business days of any stock transaction.

Question 2

How do I interpret an insider's transaction history?

Accepted Answer

Focus on open-market purchases (Form 4 code "P"), which represent voluntary personal capital commitments. Large purchases ($100,000+), repeated buying over time, and purchases during price declines are the most meaningful signals. Option exercises, stock awards, and automatic plan transactions are less informative.

Question 3

Are insider transactions reliable investment signals?

Accepted Answer

Insider buying is generally a more reliable signal than selling. Insiders buy for one primary reason — they believe the stock will rise. The strongest buying signals involve large dollar amounts, purchases during price declines, and cluster buying where multiple insiders buy simultaneously.

Question 4

Where can I see all of Balthaser Kevin's recent Form 4 filings?

Accepted Answer

All Form 4 filings by Balthaser Kevin are available on this InsiderAct profile page, sourced directly from SEC EDGAR. Each transaction shows the date, shares bought or sold, price per share, transaction code, and resulting ownership position. You can also view the original filing on SEC EDGAR for the complete disclosure.

Question 5

What is the difference between an officer and a director insider purchase?

Accepted Answer

Officer purchases (CEOs, CFOs, COOs) are generally considered stronger signals than director purchases because officers have deeper day-to-day visibility into company operations and financials. A director may be buying for governance or relationship reasons. Both are meaningful, but C-suite officer buying carries more informational weight — especially for large, discretionary purchases.


2026-03-03	2026-03-01	ACRS Aclaris Therapeutics, Inc.	CFO	Exercise Conversion	2,375	$0.00	$0
2026-03-03	2026-03-01	ACRS Aclaris Therapeutics, Inc.	CFO	Tax Payment	677	$2.87	$1,943
2026-02-06	2026-02-02	ACRS Aclaris Therapeutics, Inc.	CFO	Award	346,800	$0.00	$0
2026-02-05	2026-02-03	ACRS Aclaris Therapeutics, Inc.	CFO	Tax Payment	6,449	$3.47	-$22,378
2026-02-05	2026-02-03	ACRS Aclaris Therapeutics, Inc.	CFO	Exercise Conversion	22,025	$0.00	$0
2026-02-03	2026-02-01	ACRS Aclaris Therapeutics, Inc.	CFO	Tax Payment	4,984	$3.51	-$17,494
2026-02-03	2026-02-01	ACRS Aclaris Therapeutics, Inc.	CFO	Exercise Conversion	14,750	$0.00	$0
2026-01-05	2026-01-02	ACRS Aclaris Therapeutics, Inc.	CFO	Exercise Conversion	13,200	$0.00	$0
2026-01-05	2026-01-02	ACRS Aclaris Therapeutics, Inc.	CFO	Tax Payment	4,461	$2.88	-$12,848
2026-01-05	2026-01-01	ACRS Aclaris Therapeutics, Inc.	CFO	Exercise Conversion	7,500	$0.00	$0

Balthaser Kevin

Latest Insider Transactions

Want to see more transactions?